2m 2m 2m 2m 2m 2m 2m
Xencor (XNCR)
NASDAQ
$14.39+$0.38 (+2.68%)
Price as of Jun 23, 2026 5:10 PM EDT- $1.0BMarket Cap
- 66.59%1-Year Change
- BiotechnologyIndustry
Xencor (XNCR)
$14.39+$0.38 (+2.68%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 125.6M +13.65% | 110.5M -36.72% | 174.6M +6.10% | 164.6M -40.18% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 125.6M +13.65% | 110.5M -36.72% | 174.6M +6.10% | 164.6M -40.18% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -239.4M +5.16% | -227.7M -10.22% | -253.6M +27.08% | -199.6M +3.67% | |
Depreciation and Amortization Expense | 10.5M -13.17% | 12.1M +5.30% | 11.5M +30.67% | 8.8M +17.46% | |
Total Operating Expenses | 303.1M +4.91% | 288.9M -5.89% | 307.0M +24.26% | 247.1M +6.79% | |
Operating Profit | -177.5M -0.51% | -178.4M +34.79% | -132.4M +60.49% | -82.5M -288.44% | |
Interest Income | 27.5M N/A | N/A N/A | 19.3M N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -6.2M N/A | N/A N/A | |
Interest Income and Expense and Net | 27.5M N/A | 0 -100.00% | 13.2M N/A | 0 N/A | |
Total Nonoperating Income and Expense | 87.9M +255.48% | -56.5M -544.02% | 12.7M -54.49% | 28.0M -28.04% | |
Income before Taxes | -89.6M -61.85% | -234.9M +96.37% | -119.6M +119.48% | -54.5M -165.97% | |
Income Taxes | 2.5M +54.85% | 1.6M -88.16% | 13.7M +1,930.01% | 673,000 N/A | |
Extraordinary Items | 9.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -91.9M -60.48% | -232.6M +74.73% | -133.1M +141.27% | -55.2M -166.78% | |
Net Income from Continuing Operations Applicable to Common | -89.6M -61.85% | -234.9M +96.37% | -119.6M +119.48% | -54.5M -165.97% | |
Basic EPS and Net Income | -1.24 -65.36% | -3.58 +62.73% | -2.20 +136.56% | -0.93 -165.49% | |
Diluted EPS and Net Income | -1.24 -65.36% | -3.58 +62.73% | -2.20 +136.56% | -0.93 -167.88% | |
Basic Weighted Average Shares | 74.2M +14.14% | 65.0M +7.50% | 60.5M +1.43% | 59.7M +2.18% | |
Diluted Weighted Average Shares | 74.2M +14.14% | 65.0M +7.50% | 60.5M +1.43% | 59.7M -1.39% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 54.1M +32.29% | 40.9M -24.01% | 53.8M -0.28% | 53.9M -62.40% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 54.1M +32.29% | 40.9M -24.01% | 53.8M -0.28% | 53.9M -62.40% | |
Total Current Assets | 599.8M +3.85% | 577.6M -9.13% | 635.6M -5.88% | 675.3M +59.14% | |
Accumulated Depreciation | 51.5M +22.03% | 42.2M +16.43% | 36.2M +28.06% | 28.3M +23.92% | |
Property and Plant and Equipment and Net | 53.3M -10.86% | 59.8M -9.56% | 66.1M +11.73% | 59.2M +109.57% | |
Total Long-Term Assets | 498,000 0.00% | 498,000 -23.15% | 648,000 +5.71% | 613,000 -6.13% | |
Total Assets | 875.5M -8.03% | 951.9M -1.37% | 965.1M +14.05% | 846.3M +0.96% | |
Income Taxes Payable | 6.4M -36.21% | 10.0M +88.81% | 5.3M N/A | N/A N/A | |
Total Short-Term Debt | 43.3M -10.69% | 48.4M +74.83% | 27.7M N/A | N/A N/A | |
Total Current Liabilities | 95.9M +9.69% | 87.4M +18.29% | 73.9M +15.77% | 63.8M -9.75% | |
Total Long-Term Debt | 76.5M -33.59% | 115.2M -28.81% | 161.8M N/A | N/A N/A | |
Total Long-Term Liabilities | 141.2M -21.76% | 180.5M -18.25% | 220.8M +301.99% | 54.9M +61.69% | |
Total Liabilities | 239.9M -13.68% | 277.9M -8.29% | 303.0M +155.16% | 118.8M +13.43% | |
Retained Earnings | -796.0M +13.06% | -704.0M +49.34% | -471.4M +39.36% | -338.3M +19.49% | |
Total Stockholders Equity | 635.6M -6.20% | 677.6M +2.40% | 661.8M -9.04% | 727.5M -0.82% | |
Total Shares Outstanding | 71.9M +2.30% | 70.3M +15.18% | 61.0M +1.67% | 60.0M +1.08% | |
Cash Flow | |||||
Cash from Operating Activities | -135.1M -33.17% | -202.2M +159.46% | -77.9M -418.26% | 24.5M +245.29% | |
Capital Expenditures | 3.1M -48.34% | 6.1M -66.95% | 18.4M -52.08% | 38.5M +189.45% | |
Cash from Investing Activities | 140.0M +1,878.26% | -7.9M -92.91% | -111.1M -7.23% | -119.7M +158.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.2M -95.82% | 197.2M +4.19% | 189.2M +3,218.47% | 5.7M -86.75% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -141.35% -12.46% | -161.47% +113.01% | -75.80% +51.27% | -50.11% -414.99% | |
Return on Assets | -10.06% -58.54% | -24.27% +65.09% | -14.70% +124.36% | -6.55% -161.11% | |
Return on Equity | -14.00% -59.70% | -34.74% +81.23% | -19.17% +153.73% | -7.55% -159.69% | |
Revenue Growth | 13.65% +137.17% | -36.72% -702.20% | 6.10% +115.18% | -40.18% -132.34% | |
Current Ratio | 6.25 -5.33% | 6.61 -23.17% | 8.60 -18.71% | 10.58 +76.32% | |
Cash Ratio | 0.56 +20.60% | 0.47 -35.76% | 0.73 -13.87% | 0.84 -58.34% | |
Debt-to-Equity Ratio | 0.19 -21.96% | 0.24 -15.68% | 0.29 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.14 -20.42% | 0.17 -12.43% | 0.20 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow